AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 35 filers reported holding AURA BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,987,653 | -24.5% | 221,589 | +3.9% | 0.00% | -100.0% |
| Q2 2023 | $2,633,490 | +45.2% | 213,238 | +9.1% | 0.00% | – |
| Q1 2023 | $1,813,507 | +20.1% | 195,421 | +35.9% | 0.00% | – |
| Q4 2022 | $1,510,058 | -42.6% | 143,815 | -0.9% | 0.00% | -100.0% |
| Q3 2022 | $2,629,000 | +39.8% | 145,101 | +9.4% | 0.00% | – |
| Q2 2022 | $1,881,000 | +85.7% | 132,692 | +188.0% | 0.00% | – |
| Q1 2022 | $1,013,000 | +30.0% | 46,071 | +0.4% | 0.00% | – |
| Q4 2021 | $779,000 | – | 45,875 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $37,542,666 | 10.52% |
| Regency Capital Management Inc.\DE | 532,333 | $6,574,313 | 5.72% |
| Decheng Capital Management III (Cayman), LLC | 293,333 | $3,622,663 | 1.14% |
| Nantahala Capital Management | 803,325 | $9,921,064 | 0.96% |
| Matrix Capital Management Company, LP | 5,362,870 | $66,231,445 | 0.77% |
| Eventide Asset Management | 2,935,519 | $36,253,660 | 0.61% |
| Rock Springs Capital Management LP | 1,019,757 | $12,593,999 | 0.30% |
| Long Focus Capital Management, LLC | 180,175 | $2,225,161 | 0.10% |
| LEVIN CAPITAL STRATEGIES, L.P. | 70,000 | $864,500 | 0.10% |
| TBH Global Asset Management, LLC | 33,097 | $408,752 | 0.08% |